Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• ACC CardiaCast: In Case You Missed It: ACC.26 ATTR-CM Treatment Updates
  This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for currently available disease-modifying therapies.
• Did Disparities in ICD Implantations Worsen During the COVID-19 Pandemic? | NCDR Study
  The incidence of ICD implantations declined significantly during the COVID-19 pandemic, according to a recent study published in Heart Rhythm. Although disparities by sex, race and ethnicity persisted during peak COVID, they did not worsen.
• AFib Ablation Approaches Differ by Hospital Teaching Status | NCDR Study
  Procedural approaches for atrial fibrillation (AFib) ablation differ by hospital teaching status; however, overall complication rates are similar, according to a recent study published in JAHA.
• ACC CardiaCast: The Evolving Role of PCSK9 Inhibitors in LDL-C Management
  In this episode of CardiaCast, Dr. Michael Blaha will be joined by Dr. Ann Marie Navar to discuss the 2026 updates to ACC/AHA guideline on management of dyslipidemia and key clinical trial data supporting the use of PCSK9 inhibitors in getting patients to their lipid goals.
• Clinical Obesity Emerges as Independent Risk Factor For New-Onset HF, Mortality
  A cohort study published May 4 in JACC: Asia identified clinical obesity as a risk factor for new-onset heart failure (HF) and all-cause mortality, largely due to related clinical conditions and excess weight. Treating clinical obesity as an independent disease may increase the effectiveness of HF prevention strategies.